FDA panel recommends approval of Theratechnologies' tesamorelin

05/27/2010 | Reuters

Theratechnologies got the unanimous endorsement of an FDA panel for tesamorelin, a drug that reduces abdominal fat in HIV patients. The FDA is scheduled to issue an approval decision by July 27.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA